CytomX Therapeutics
CTMX
CTMX
126 hedge funds and large institutions have $249M invested in CytomX Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-4
Holders Change %
-3.08%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
43
Reduced
51
Closed
15
Calls
$88K
Puts
–
Net Calls
+$88K
Net Calls Change
+$22K
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$36.5M |
| 2 |
2
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.38M |
| 3 |
3
Morgan Stanley
New York
|
$1.98M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$6.85M |
| 5 |
5
Arrowstreet Capital
Boston,
Massachusetts
|
$1.87M |
Top Sellers
| 1 |
1
First Manhattan
New York
|
$0 |
| 2 |
2
BlackRock
New York
|
$24.9M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$0 |
| 4 |
4
Russell Investments Group
London,
United Kingdom
|
$1.5M |
| 5 |
5
Renaissance Technologies
New York
|
$13.5M |
